Logo image of WEST

WESTROCK COFFEE CO (WEST) Stock Fundamental Analysis

NASDAQ:WEST - Nasdaq - US96145W1036 - Common Stock - Currency: USD

6.29  -0.06 (-0.94%)

Fundamental Rating

1

WEST gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 90 industry peers in the Food Products industry. WEST has a bad profitability rating. Also its financial health evaluation is rather negative. WEST has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

WEST had negative earnings in the past year.
In the past year WEST has reported a negative cash flow from operations.
WEST Yearly Net Income VS EBIT VS OCF VS FCFWEST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of WEST (-4.07%) is worse than 73.81% of its industry peers.
With a Return On Equity value of -10.18%, WEST is not doing good in the industry: 72.62% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROIC N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WEST Yearly ROA, ROE, ROICWEST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -50 -100

1.3 Margins

WEST has a Gross Margin of 16.27%. This is in the lower half of the industry: WEST underperforms 63.10% of its industry peers.
The Profit Margin and Operating Margin are not available for WEST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEST Yearly Profit, Operating, Gross MarginsWEST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 -5 10 15

More info and screens

1

2. Health

2.1 Basic Checks

WEST does not have a ROIC to compare to the WACC, probably because it is not profitable.
WEST has more shares outstanding than it did 1 year ago.
WEST has a worse debt/assets ratio than last year.
WEST Yearly Shares OutstandingWEST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
WEST Yearly Total Debt VS Total AssetsWEST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.27, we must say that WEST is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of WEST (1.27) is worse than 72.62% of its industry peers.
WEST has a Debt/Equity ratio of 0.89. This is a neutral value indicating WEST is somewhat dependend on debt financing.
The Debt to Equity ratio of WEST (0.89) is worse than 72.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.27
ROIC/WACCN/A
WACC8.76%
WEST Yearly LT Debt VS Equity VS FCFWEST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

WEST has a Current Ratio of 1.31. This is a normal value and indicates that WEST is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.31, WEST is in line with its industry, outperforming 40.48% of the companies in the same industry.
WEST has a Quick Ratio of 1.31. This is a bad value and indicates that WEST is not financially healthy enough and could expect problems in meeting its short term obligations.
WEST has a worse Quick ratio (0.68) than 65.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.68
WEST Yearly Current Assets VS Current LiabilitesWEST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

WEST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.86%.
Looking at the last year, WEST shows a decrease in Revenue. The Revenue has decreased by -0.36% in the last year.
EPS 1Y (TTM)-22.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.67%
Revenue 1Y (TTM)-0.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.57%

3.2 Future

WEST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.40% yearly.
The Revenue is expected to grow by 10.28% on average over the next years. This is quite good.
EPS Next Y-55.43%
EPS Next 2Y29.65%
EPS Next 3Y29.4%
EPS Next 5YN/A
Revenue Next Year-3.51%
Revenue Next 2Y7.64%
Revenue Next 3Y10.28%
Revenue Next 5YN/A

3.3 Evolution

WEST Yearly Revenue VS EstimatesWEST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
WEST Yearly EPS VS EstimatesWEST Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WEST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year WEST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEST Price Earnings VS Forward Price EarningsWEST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WEST indicates a slightly more expensive valuation: WEST is more expensive than 65.48% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.78
WEST Per share dataWEST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as WEST's earnings are expected to grow with 29.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.65%
EPS Next 3Y29.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WEST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WESTROCK COFFEE CO

NASDAQ:WEST (2/24/2025, 1:04:09 PM)

6.29

-0.06 (-0.94%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)03-11 2025-03-11/amc
Inst Owners33.31%
Inst Owner Change-89.99%
Ins Owners4.9%
Ins Owner Change0.42%
Market Cap592.46M
Analysts84
Price Target11.63 (84.9%)
Short Float %15.97%
Short Ratio20.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3070.57%
Min EPS beat(2)-6671.48%
Max EPS beat(2)530.34%
EPS beat(4)1
Avg EPS beat(4)-2146.95%
Min EPS beat(4)-6671.48%
Max EPS beat(4)530.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.65%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-6.76%
Revenue beat(4)0
Avg Revenue beat(4)-7.83%
Min Revenue beat(4)-8.54%
Max Revenue beat(4)-6.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.33%
PT rev (3m)-6.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.37%
Revenue NY rev (3m)-5.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.55
P/FCF N/A
P/OCF N/A
P/B 1.53
P/tB 3.98
EV/EBITDA 34.78
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-2.43
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS11.36
BVpS4.12
TBVpS1.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.27%
FCFM N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 15.65
Cap/Depr 619.86%
Cap/Sales 15.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.68
Altman-Z 1.27
F-Score2
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)327.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.67%
EPS Next Y-55.43%
EPS Next 2Y29.65%
EPS Next 3Y29.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.57%
Revenue Next Year-3.51%
Revenue Next 2Y7.64%
Revenue Next 3Y10.28%
Revenue Next 5YN/A
EBIT growth 1Y-133.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1139.04%
EBIT Next 3Y219.97%
EBIT Next 5YN/A
FCF growth 1Y-90.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.13%
OCF growth 3YN/A
OCF growth 5YN/A